Ticker: IMMX

Immix Biopharma, Inc. (NASDAQ: IMMX) is a clinical-stage biopharmaceutical company focused on developing cell therapies, particularly for AL Amyloidosis. As of June 30, 2025, the company reported significant financial metrics and activity updates revealing both challenges and opportunities. Key P...

Company Overview: Immix Biopharma, Inc. (NASDAQ: IMMX) is a biotechnology company focused on advancing next-generation immunotherapies. The company is in a phase of growing its operations and refining its financial reporting. Recent Developments: Immix Biopharma’s most recent filing, an amendment...